I have high expectations for RVP, there is currently a large needle shortage worldwide for Covid vaccines and RVP is the leading manufacturer of automated retraction syringes.
RVP's EPS went from .014 to .5 in one year, growing earnings and revenue. RVP is held by 54% insiders. although an insider sold $3m of his shares, it only reduced insider holdings by 1.3%.
price bounced nicely off the 200ma on Jan 14 and hasn't come back to test it. RVP was mentioned by Motley Fool on Friday again.
My entries are in the mid 12s with a target of 20.
RVP's EPS went from .014 to .5 in one year, growing earnings and revenue. RVP is held by 54% insiders. although an insider sold $3m of his shares, it only reduced insider holdings by 1.3%.
price bounced nicely off the 200ma on Jan 14 and hasn't come back to test it. RVP was mentioned by Motley Fool on Friday again.
My entries are in the mid 12s with a target of 20.
Transaction en cours:
took profits around 16.30, will re-enter at dip for long shares